Gilpin Wealth Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7
Closed -$415 1098
2026
Q1
$415 Buy
7
+4
+133% +$260 ﹤0.01% 675
2025
Q4
$186 Buy
+3
New +$184 ﹤0.01% 680

Other funds holding PBH

Gilpin Wealth Management's PBH Position: Q2 2026 in Review

Gilpin Wealth Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 7 shares — an estimated $415 sold.

Gilpin Wealth Management first reported a position in PBH in Q4 2025 and held it in 2 quarters. The position peaked at $415 in Q1 2026. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Gilpin Wealth Management reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Gilpin Wealth Management sold 7 Prestige Consumer Healthcare shares in Q2 2026, an estimated $415.
  • Gilpin Wealth Management first reported a position in Prestige Consumer Healthcare in Q4 2025 and held it in 2 quarters.
  • Gilpin Wealth Management's Prestige Consumer Healthcare position peaked at $415 in Q1 2026.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Gilpin Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.